{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T19:27:53Z","timestamp":1783970873927,"version":"3.55.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T00:00:00Z","timestamp":1728000000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T00:00:00Z","timestamp":1728000000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1038\/s41440-024-01908-z","type":"journal-article","created":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T05:02:13Z","timestamp":1728018133000},"page":"3423-3433","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Suppressing the expression of steroidogenic acute regulatory protein (StAR) in the myocardium by spironolactone contributes to the improvement of right ventricular remodeling in pulmonary arterial hypertension"],"prefix":"10.1038","volume":"47","author":[{"given":"Hideki","family":"Imano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuo","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saori","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Kohda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiro","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasukatsu","family":"Izumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Yoshiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinobu","family":"Hirose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Ohta-Ogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatsue","family":"Ishibashi-Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuji","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,4]]},"reference":[{"key":"1908_CR1","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1161\/CIRCULATIONAHA.109.927681","volume":"121","author":"K Abe","year":"2010","unstructured":"Abe K, Toba M, Alzoubi A, Ito M, Fagan KA, Cool CD, et al. Formation of plexiform lesions in experimental severe pulmonary arterial hypertension. Circulation. 2010;121:2747\u201354. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.927681","journal-title":"Circulation"},{"key":"1908_CR2","doi-asserted-by":"publisher","first-page":"589","DOI":"10.2174\/1570161115666170427154217","volume":"15","author":"E Woo","year":"2017","unstructured":"Woo E, Kato R, Imano H, Fujiwara Y, Ijiri Y, Okada Y, et al. Capillary degeneration and right ventricular remodeling due to hypoxic stress with Sugen5416. Curr Vasc Pharm. 2017;15:589\u201398. https:\/\/doi.org\/10.2174\/1570161115666170427154217","journal-title":"Curr Vasc Pharm"},{"key":"1908_CR3","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/j.ejheart.2008.09.012","volume":"10","author":"M Minnaard-Huiban","year":"2008","unstructured":"Minnaard-Huiban M, Hermans JJ, Essen HV, Bitsch N, Smits JF. Comparison of the effects of intrapericardial and intravenous aldosterone infusions on left ventricular fibrosis in rats. Eur J Heart Fail. 2008;10:1166\u201371. https:\/\/doi.org\/10.1016\/j.ejheart.2008.09.012","journal-title":"Eur J Heart Fail"},{"key":"1908_CR4","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1177\/1470320312460897","volume":"14","author":"Y Qian","year":"2013","unstructured":"Qian Y, Liu Y, Tang H, Zhou W, Jiang L, Li Y, et al. Circulating and local renin-angiotensin-aldosterone system express differently in atrial fibrillation patients with different types of mitral valvular disease. J Renin Angiotensin Aldosterone Syst. 2013;14:204\u201311. https:\/\/doi.org\/10.1177\/1470320312460897","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"1908_CR5","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1046\/j.1523-1755.2000.00973.x","volume":"57","author":"C Delcayre","year":"2000","unstructured":"Delcayre C, Silvestre JS, Garnier A, Oubenaissa A, Cailmail S, Tatara E, et al. Cardiac aldosterone production and ventricular remodeling. Kidney Int. 2000;57:1346\u201351. https:\/\/doi.org\/10.1046\/j.1523-1755.2000.00973.x","journal-title":"Kidney Int"},{"key":"1908_CR6","doi-asserted-by":"publisher","first-page":"12A","DOI":"10.1016\/0002-9149(93)90239-9","volume":"71","author":"CG Brilla","year":"1993","unstructured":"Brilla CG, Matsubara LS, Weber KT. Antifibrotic effects of spironolactone in preventing myocardial fibrosis in systemic arterial hypertension. Am J Cardiol. 1993;71:12A\u201316A. https:\/\/doi.org\/10.1016\/0002-9149(93)90239-9","journal-title":"Am J Cardiol"},{"key":"1908_CR7","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1086\/675984","volume":"4","author":"BA Maron","year":"2014","unstructured":"Maron BA, Leopold JA. The role of the renin-angiotensin-aldosterone system in the pathobiology of pulmonary arterial hypertension (2013 Grover Conference series). Pulm Circ. 2014;4:200\u201310. https:\/\/doi.org\/10.1086\/675984","journal-title":"Pulm Circ"},{"key":"1908_CR8","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1161\/CIRCULATIONAHA.112.094722","volume":"126","author":"BA Maron","year":"2012","unstructured":"Maron BA, Zhang YY, White K, Chan SY, Handy DE, Mahoney CE, et al. Aldosterone inactivates the endothelin-B receptor via a cysteinyl thiol redox switch to decrease pulmonary endothelial nitric oxide levels and modulate pulmonary arterial hypertension. Circulation. 2012;126:963\u201374. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.112.094722","journal-title":"Circulation"},{"key":"1908_CR9","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1161\/CIRCULATIONAHA.113.007690","volume":"130","author":"BA Maron","year":"2014","unstructured":"Maron BA, Oldham WM, Chan SY, Vargas SO, Arons E, Zhang YY, et al. Upregulation of steroidogenic acute regulatory protein by hypoxia stimulates aldosterone synthesis in pulmonary artery endothelial cells to promote pulmonary vascular fibrosis. Circulation. 2014;130:168\u201379. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.113.007690","journal-title":"Circulation"},{"key":"1908_CR10","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1111\/1440-1681.12125","volume":"40","author":"KV Barrett","year":"2013","unstructured":"Barrett KV, McCurley AT, Jaffe IZ. Direct contribution of vascular mineralocorticoid receptors to blood pressure regulation. Clin Exp Pharm Physiol. 2013;40:902\u20139. https:\/\/doi.org\/10.1111\/1440-1681.12125","journal-title":"Clin Exp Pharm Physiol"},{"key":"1908_CR11","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1002\/ejhf.1979","volume":"22","author":"FH Verbrugge","year":"2020","unstructured":"Verbrugge FH, Damman K. Spironolactone: diuretic or disease-modifying drug in heart failure with preserved ejection fraction? Eur J Heart Fail. 2020;22:1611\u201314. https:\/\/doi.org\/10.1002\/ejhf.1979","journal-title":"Eur J Heart Fail"},{"key":"1908_CR12","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1164\/rccm.200604-547OC","volume":"174","author":"PR Forfia","year":"2006","unstructured":"Forfia PR, Fisher MR, Mathai SC, Housten-Harris T, Hemnes AR, Borlaug BA, et al. Tricuspid annular displacement predicts survival in pulmonary hypertension. Am J Respir Crit Care Med. 2006;174:1034\u201341. https:\/\/doi.org\/10.1164\/rccm.200604-547OC","journal-title":"Am J Respir Crit Care Med"},{"key":"1908_CR13","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ijcard.2016.10.009","volume":"225","author":"E Aloia","year":"2016","unstructured":"Aloia E, Cameli M, D\u2019Ascenzi F, Sciaccaluga C, Mondillo S. TAPSE: an old but useful tool in different diseases. Int J Cardiol. 2016;225:177\u201383. https:\/\/doi.org\/10.1016\/j.ijcard.2016.10.009","journal-title":"Int J Cardiol"},{"key":"1908_CR14","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/s0002-9149(01)02056-2","volume":"88","author":"Y Mori","year":"2001","unstructured":"Mori Y, Rice MJ, McDonald RW, Reller MD, Wanitkun S, Harada K, et al. Evaluation of systolic and diastolic ventricular performance of the right ventricle in fetuses with ductal constriction using the Doppler Tei index. Am J Cardiol. 2001;88:1173\u20138. https:\/\/doi.org\/10.1016\/s0002-9149(01)02056-2","journal-title":"Am J Cardiol"},{"key":"1908_CR15","doi-asserted-by":"publisher","first-page":"H1062","DOI":"10.1152\/ajpheart.00150.2011","volume":"30","author":"T Hayashi","year":"2011","unstructured":"Hayashi T, Yoshioka T, Hasegawa K, Miyamura M, Mori T, Ukimura A, et al. Inhalation of hydrogen gas attenuates left ventricular remodeling induced by intermittent hypoxia in mice. Am J Physiol Heart Circ Physiol. 2011;30:H1062\u20139. https:\/\/doi.org\/10.1152\/ajpheart.00150.2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1908_CR16","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/0002-8703(95)90116-7","volume":"129","author":"T Hayashi","year":"1995","unstructured":"Hayashi T, James TN, Buckingham DC. Ultrastructure and immunohistochemistry of the coronary chemoreceptor in human and canine hearts. Am Heart J. 1995;129:946\u201359.","journal-title":"Am Heart J"},{"key":"1908_CR17","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1093\/cvr\/cvx145","volume":"113","author":"CEE van der Bruggen","year":"2017","unstructured":"van der Bruggen CEE, Tedford RJ, Handoko ML, van der Velden J, de Man FS. RV pressure overload: from hypertrophy to failure. Cardiovasc Res. 2017;113:1423\u201332. https:\/\/doi.org\/10.1093\/cvr\/cvx145","journal-title":"Cardiovasc Res"},{"key":"1908_CR18","doi-asserted-by":"publisher","DOI":"10.1177\/20458940211025240","volume":"11","author":"DP Menon","year":"2021","unstructured":"Menon DP, Qi G, Kim SK, Moss ME, Penumatsa KC, Warburton RR, et al. Vascular cell-specific roles of mineralocorticoid receptors in pulmonary hypertension. Pulm Circ. 2021;11:20458940211025240. https:\/\/doi.org\/10.1177\/20458940211025240","journal-title":"Pulm Circ"},{"key":"1908_CR19","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1161\/HYPERTENSIONAHA.120.16196","volume":"78","author":"J Kowalski","year":"2021","unstructured":"Kowalski J, Deng L, Suennen C, Koca D, Meral D, Bode C, et al. Eplerenone improves pulmonary vascular remodeling and hypertension by inhibition of the mineralocorticoid receptor in endothelial cells. Hypertension. 2021;78:456\u201365. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.120.16196","journal-title":"Hypertension"},{"key":"1908_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1374506","volume":"15","author":"H Zhao","year":"2024","unstructured":"Zhao H, Song J, Li X, Xia Z, Wang Q, Fu J, et al. The role of immune cells and inflammation in pulmonary hypertension: mechanisms and implications. Front Immunol. 2024;15:1374506 https:\/\/doi.org\/10.3389\/fimmu.2024.1374506","journal-title":"Front Immunol"},{"key":"1908_CR21","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/cpt1976192177","volume":"19","author":"A Karim","year":"1976","unstructured":"Karim A, Zagarella J, Hutsell TC, Dooley M. Spironolactone. III. Canrenone\u2013maximum and minimum steady-state plasma levels. Clin Pharm Ther. 1976;19:177\u201382. https:\/\/doi.org\/10.1002\/cpt1976192177","journal-title":"Clin Pharm Ther"},{"issue":"Jun","key":"1908_CR22","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/med.0b013e3283391989","volume":"17","author":"KC Gilbert","year":"2010","unstructured":"Gilbert KC, Brown NJ. Aldosterone and inflammation. Curr Opin Endocrinol Diabetes Obes. 2010;17(Jun):199\u2013204. https:\/\/doi.org\/10.1097\/med.0b013e3283391989","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"1908_CR23","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1248\/bpb.b20-01011","volume":"44","author":"H Imano","year":"2021","unstructured":"Imano H, Kato R, Nomura A, Tamura M, Yamaguchi Y, Ijiri Y, et al. Rivaroxaban attenuates right ventricular remodeling in rats with pulmonary arterial hypertension. Biol Pharm Bull. 2021;44:669\u201377. https:\/\/doi.org\/10.1248\/bpb.b20-01011","journal-title":"Biol Pharm Bull"},{"key":"1908_CR24","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1093\/cvr\/cvx198","volume":"114","author":"JM Elinoff","year":"2018","unstructured":"Elinoff JM, Chen LY, Dougherty EJ, Awad KS, Wang S, Biancotto A, et al. Spironolactone-induced degradation of the TFIIH core complex XPB subunit suppresses NF-\u03baB and AP-1 signalling. Cardiovasc Res. 2018;114:65\u201376. https:\/\/doi.org\/10.1093\/cvr\/cvx198","journal-title":"Cardiovasc Res"},{"key":"1908_CR25","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1159\/000487871","volume":"45","author":"A Han","year":"2018","unstructured":"Han A, Lu Y, Zheng Q, Zhang J, Zhao Y, Zhao M, et al. Qiliqiangxin attenuates cardiac remodeling via inhibition of TGF-\u03b21\/Smad3 and NF-\u03baB signaling pathways in a rat model of myocardial infarction. Cell Physiol Biochem. 2018;45:1797\u2013806. https:\/\/doi.org\/10.1159\/000487871","journal-title":"Cell Physiol Biochem"},{"key":"1908_CR26","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1007\/s11033-019-05222-7","volume":"47","author":"WW Zhang","year":"2020","unstructured":"Zhang WW, Zheng RH, Bai F, Sturdivant K, Wang NP, James EA, et al. Steroidogenic acute regulatory protein\/aldosterone synthase mediates angiotensin II-induced cardiac fibrosis and hypertrophy. Mol Biol Rep. 2020;47:1207\u201322. https:\/\/doi.org\/10.1007\/s11033-019-05222-7","journal-title":"Mol Biol Rep"},{"key":"1908_CR27","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/j.1939-4640.2001.tb02165.x","volume":"22","author":"L Luo","year":"2001","unstructured":"Luo L, Chen H, Zirkin BR. Leydig cell aging: steroidogenic acute regulatory protein (StAR) and cholesterol side-chain cleavage enzyme. J Androl. 2001;22:149\u201356.","journal-title":"J Androl"},{"key":"1908_CR28","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1161\/01.cir.0000057794.29667.08","volume":"107","author":"T Ito","year":"2003","unstructured":"Ito T, Yoshimura M, Nakamura S, Nakayama M, Shimasaki Y, Harada E, et al. Inhibitory effect of natriuretic peptides on aldosterone synthase gene expression in cultured neonatal rat cardiocytes. Circulation. 2003;107:807\u201310. https:\/\/doi.org\/10.1161\/01.cir.0000057794.29667.08","journal-title":"Circulation"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-024-01908-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-024-01908-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-024-01908-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T10:25:47Z","timestamp":1733394347000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-024-01908-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,4]]},"references-count":28,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["1908"],"URL":"https:\/\/doi.org\/10.1038\/s41440-024-01908-z","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,4]]},"assertion":[{"value":"13 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}